ALT (alanine aminotransferase)
Showing 1 - 25 of >10,000
HBV Infection, Chronic Hepatitis b Trial in China (Tenofovir Amibufenamide(TMF))
Recruiting
- HBV Infection
- Chronic Hepatitis b
- Tenofovir Amibufenamide（TMF）
-
Beijing, China
- +11 more
Mar 22, 2023
Hepatitis B Virus Trial in Guangzhou (Tenofovir alafenamide Fumarate)
Recruiting
- Hepatitis B Virus
- Tenofovir alafenamide Fumarate
-
Guangzhou, Guangdong, ChinaThird Affiliated Hospital of Sun Yat-sen University
Nov 26, 2021
ALT Routinely Recorded Remotely: A Comparator Study of Liver
Recruiting
- Elevated Alanine Transaminase (ALT)
- Tasso+ SST
-
Aurora, Colorado
- +2 more
Feb 24, 2022
Acute Pancreatitis Trial in Zagazig (diagnostic test, device, drug, combination product, dietary supplement, procedure)
Completed
- Acute Pancreatitis
- serum lipase or amylase
- +15 more
-
Zagazig, EgyptZagazig University Faculty of Human Medicine
Nov 3, 2020
Non-Alcoholic Fatty Liver Disease, Non Insulin Dependent Diabetes, ALT Trial in Long Beach (Betaine (trimethyglycine))
Unknown status
- Non-Alcoholic Fatty Liver Disease
- +2 more
- Betaine (trimethyglycine)
-
Long Beach, CaliforniaVA Long Beach Healthcare System
Mar 16, 2020
Chronic Hepatitis b Trial in Tainan (Tenofovir Alafenamide)
Recruiting
- Chronic Hepatitis b
- Tenofovir Alafenamide
-
Tainan, TaiwanNational Cheng-Kung University Hospital
Dec 18, 2020
Inflammatory and Anti-Inflammatory Gene Expressions in Liver
Active, not recruiting
- Liver Transplant; Complications
- +3 more
- Molecular Immunology , gene expressions
-
Malatya, Turkeyİnönü University
May 2, 2023
Role of Ultrasound in Diagnosis of Muscle Diseases
Recruiting
- Ultrasound
- Muscle Disease
- Neuromuscular Ultrasound (US)
- +2 more
-
Assiut, EgyptAssiut University Hospital
Jul 31, 2021
Significant Liver Fibrosis and Inflammation in Chronic HBV
Not yet recruiting
- Chronic Hepatitis b
- (no location specified)
Aug 7, 2022
Nonalcoholic Fatty Liver Disease Trial in Jerusalem (Anti-human CCL24 mAb (CM-101) - Part One, Anti-human CCL24 mAb (CM-101) -
Completed
- Nonalcoholic Fatty Liver Disease
- Anti-human CCL24 monoclonal antibody (CM-101) - Part One
- +3 more
-
Jerusalem, IsraelHadassah University Hospital - Ein Kerem
Sep 13, 2023
Autoimmune Hepatitis Trial in Indianapolis (zetomipzomib, )
Recruiting
- Autoimmune Hepatitis
- zetomipzomib
- placebo
-
Indianapolis, IndianaIndiana University
Jan 13, 2023
Non-alcoholic Fatty Liver Disease Trial in Pozzilli (nutraceutical mixture, )
Completed
- Non-alcoholic Fatty Liver Disease
- nutraceutical mixture
- placebo
-
Pozzilli, Isernia, ItalyIRCCS Neuromed
Jan 11, 2022
High Plasma Liver Enzymes After Burn Trial (resistance band)
Not yet recruiting
- High Plasma Liver Enzymes After Burn
- resistance band
- (no location specified)
Sep 28, 2023
NAFLD Trial (Diet and exercise, NAC with diet and exercise)
Not yet recruiting
- NAFLD
- Diet and exercise
- NAC with diet and exercise
- (no location specified)
Oct 26, 2022
Non-Alcoholic Fatty Liver Disease Trial in New Taipei City (Placebo, Probiotics)
Recruiting
- Non-Alcoholic Fatty Liver Disease
- Placebo
- Probiotics
-
New Taipei City, TaiwanFu Jen Catholic University Hospital
Jul 20, 2022
Inflammatory Response, Metabolic Disturbance Trial (Group fructose, Group Sucrose, Group Glucose)
Completed
- Inflammatory Response
- Metabolic Disturbance
- Group fructose
- +2 more
- (no location specified)
Oct 5, 2022
Fatty Liver, Nonalcoholic, Liver Function Trial in Giza (low level laser, Mediterranean diet)
Completed
- Fatty Liver, Nonalcoholic
- Liver Function
- low level laser
- Mediterranean diet
-
Giza, Dokki, EgyptCairo
Sep 25, 2021
Patients With Hepatitis D Virus (HDV) Infection in China
Not yet recruiting
- Hepatitis D
-
Beijing, Beijing, ChinaBejing Tsinghua Changgung Hospital
Jul 7, 2022
Liver Dysfunction, Sepsis-associated Liver Dysfunction Trial in Nanjing (initial aspartate aminotransferase (AST) to platelet
Recruiting
- Liver Dysfunction
- Sepsis-associated Liver Dysfunction
- initial aspartate aminotransferase (AST) to platelet (PLT) ratio index
-
Nanjing, Jiangsu, ChinaInstitute of General Surgery of Jinling Hospital
Aug 11, 2023
Atherosclerotic Cardiovascular Disease, Older Patients, LDL Cholesterol Trial (Achieving a Target LDL-C level of 25mg/dL=
Not yet recruiting
- Atherosclerotic Cardiovascular Disease
- +2 more
- Achieving a Target LDL-C level of 25mg/dL≤ LDL-C<70mg/dL
- Achieving a Target LDL-C level of 70mg/dL≤ LDL-C<100mg/dL
- (no location specified)
Mar 14, 2023
Occult Hepatitis B Virus Infection(OBI) in Chronic Hepatitis
Recruiting
- Chronic Hepatitis b
- test of HBV DNA
-
Xi'an, Shaanxi, ChinaFirst Affiliated Hospital of Xi'an JiaotongUniversity
Mar 28, 2022
NAFLD, Diabetes Trial in Durham (behavioral, drug, diagnostic test)
Not yet recruiting
- NAFLD
- Diabetes Mellitus
- NAFLD Education
- +3 more
-
Durham, North CarolinaDuke University Healthcare System
Apr 25, 2023
Liver Functions Trial in Riyadh (Aerobic training)
Completed
- Liver Functions
- Aerobic training
-
Riyadh, Saudi ArabiaKing Saud University
Jan 19, 2023
Healthy Adults Trial in Auburn (CBD oil, Placebo)
Recruiting
- Healthy Adults
- CBD oil
- Placebo
-
Auburn, AlabamaAuburn University
Jan 12, 2023
Chronic Hepatitis b, Anti-PD-1 Antibody Trial in Chongqing (Anti-PD-1 antibody, NAs)
Not yet recruiting
- Chronic Hepatitis b
- Anti-PD-1 Antibody
- Anti-PD-1 antibody
- NAs
-
Chongqing, Chongqing, ChinaThe 2nd affiliated Hospital of Chongqing Medical University
Mar 3, 2023